Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 1 962 | déclaré | 02 janv. 2026 | tx 256+499 493−599 660 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 02 janv. 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 155 | 0.00 USD | |
| 02 janv. 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1 962 | 0.00 USD | deriv |
| 30 déc. 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 9 212 | 520.01 USD | |
| 30 déc. 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 6 188 | 774.03 USD | |
| 30 déc. 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 9 212 | 0.00 USD | deriv |
| 31 déc. 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 1 948 | 708.19 USD | |
| 31 déc. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3 338 | 413.33 USD | |
| 02 janv. 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 166 | 0.00 USD | |
| 02 janv. 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1 958 | 0.00 USD | deriv |
| 31 déc. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3 338 | 0.00 USD | deriv |
| 04 sept. 2024 | GIFT | REGENERON PHARMACEUTICALS, INC. | 1 200 | 0.00 USD | |
| 03 mai 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 877 | 942.53 USD | |
| 03 mai 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2 000 | 413.33 USD | |
| 03 mai 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2 000 | 0.00 USD | deriv |
| 26 févr. 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 500 | 995.00 USD | |
| 26 févr. 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 500 | 990.00 USD | |
| 26 févr. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 413.33 USD | |
| 26 févr. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 413.33 USD | |
| 26 févr. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 0.00 USD | deriv |
| 22 févr. 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 970.00 USD | |
| 22 févr. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 413.33 USD | |
| 23 févr. 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 500 | 985.00 USD | |
| 22 févr. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 413.33 USD | |
| 22 févr. 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 960.00 USD | |
| 22 févr. 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 965.00 USD |